Shares of Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback